According to TechSci Research report, “Global Bio-Implants Market By Type (Cardiovascular Bioimplants, Dental Bioimplants, Orthopedic Bioimplants, Spinal Bioimplants, and Ophthalmology Bioimplants), By Material (Metallic Biomaterials, Ceramic Biomaterials, Polymers Biomaterials, Alloys and Natural Biomaterials), By Origin (Autograft, Allograft, Synthetic, and Others), By End-User (Hospitals, Clinics, Specialty Centers and Others), By Region, Competition, Forecast & Opportunities, 2025”, global bio-implants market is expected to witness robust growth during the forecast period. Rising cases of bone degeneration cases among geriatric population is one of the major factors accounting for the growth of global bio-implants market. Moreover, technological advancement in healthcare sector is expected to bode well for the growth of global bio-implants market through the forecast period. In addition to this, increased research and developmental activities is projected to positively influence the growth of global bio-implants market in the years to come. Also, increasing prevalence of lifestyle diseases among the population, is further making headway for the growth of global bio-implants market. However, there are some factors that might act as major impediments to the growth of global bio-implants market through 2025 including rising cost of bioimplant surgeries and high price of bioimplants.
Global bio-implants market can be segmented based on type, material, origin, end-user, company, and region. Considering the end user, the market is fragmented into hospitals, clinics, specialty centers, and others. The hospitals segment dominated the global bio-implants market until 2019 and is further anticipated to maintain its dominance during the forecast period as well which can be attributed to large patient footfall. Additionally, favorable reimbursement policies for costly implants, such as pacemakers, in government hospitals is further anticipated to boost the growth of segment during the forecast period. In terms of origin, the market can be categorized into autograft, allograft, synthetic, and others. The allografts segment is expected to register high growth during the next five years which is attributable to benefits such as lower risk of harvest site morbidity, reduced postoperative pain, as well as shorter surgical and recovery time.
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022